Abstract Alcohol use is linked to distributed structural brain alterations, but population-level alcohol-related neurobiology remains difficult to quantify. We tested whether deep learning–derived MRI representations capture reproducible variation in alcohol consumption severity and converge with clinical and biological markers. Representations were extracted from gray-matter volume maps in the German National Cohort (NAKO; N ≈ 28,000).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Patrick Bach
White matter signatures of addiction diverge across opioids, cannabis and nicotine and predict impulsive choice in cannabis dependence
Abstract White matter (WM) microstructure is implicated in the neurobiology of substance use disorders (SUDs), yet direct comparisons across substance-dependence syndromes remain scarce. It is also unclear whether WM abnormalities relate to impulsive decision-making and substance use severity.
Real-world alcohol cue exposure and drinking risk in alcohol use disorder
Abstract Alcohol-related cues are thought to contribute to drinking in alcohol use disorder (AUD), but their contribution in daily life remains difficult to separate from changing social contexts and internal states.
Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study
Keywords Psychostimulants Stimulant use disorder Stimulants Hospitalization Pharmacovigilance Register-based study Evidence before this study Prior research raised concerns that psychostimulants may increase the risk of misuse and hospitalizations, especially in individuals with stimulant use disorder.
Dihydrotestosterone and Finasteride Effects on Alcohol Cue‐Elicited Brain Activity in Males With Heavy Episodic Drinking
1 Introduction Alcohol consumption is a significant global health problem that results in a high somatic and psychological disease burden. The 2015 Addiction Survey revealed that worldwide 22.4% of men aged 18–64 years consume alcohol at a risky level and 46.5% engage in heavy episodic drinking [1].
Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol‐Related Hospitalizations: A Register Study
Significant outcomes ○ Exposure to pharmacological treatments for alcohol use disorder (naltrexone, disulfiram, acamprosate, nalmefene) is associated with a lower risk of alcohol-related hospitalizations in individuals with alcohol use disorder. ○ Exposure to naltrexone or disulfiram, or a combination of both, was significantly associated with a lower risk of alcohol-related hospitalizations, while acamprosate and nalmefene were not.
The ReCoDe addiction research consortium: Losing and regaining control over drug intake-Findings and future perspectives
1 INTRODUCTION In 2019, we established a collaborative research centre, which brings together three renowned locations (Berlin, Dresden, Mannheim) of addiction research in Germany.
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
References Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019 Sep;5(9):eaax4043. doi: 10.1126/sciadv.aax4043 PubMed Web of Science ®Google Scholar Griswold MG, Fullman N, Hawley C. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2018 Sep 22;392(10152):1015–1035. PubMed Web of Science ®Google Scholar Ray LAP, Bujarski SP, Grodin EP, et al.
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
ABSTRACT Introduction Alcohol Use Disorder (AUD) poses an ongoing significant global health burden. AUD is highly prevalent and affects not only the individuals with AUD, but also their communities and society at large. Even though pharmacotherapy is an integral part of AUD treatment, the few available substances show limited efficacy and limited clinical impact. Thus, there is a need for new innovative pharmacotherapeutic approaches.
Stress-Induced Sensitization of Insula Activation Predicts Alcohol Craving and Alcohol Use in Alcohol Use Disorder
Abstract Externe IDs PubMed 37678541 Schlagworte Alcohol use disorder, Cortisol, Craving, Cue reactivity, fMRI, Stress
Stress-induced sensitization of insula activation predicts alcohol craving and alcohol use in alcohol use disorder
ABSTRACT Stress and alcohol cues trigger alcohol consumption and relapse in alcohol use disorder (AUD). However, the neurobiological processes underlying their interaction are only little understood. Thus, we conducted a randomized, controlled neuroimaging study to investigate the effects of psychosocial stress on neural cue-reactivity and addictive behaviors. Neural alcohol cue-reactivity was assessed in 91 individuals with AUD using a validated functional magnetic resonance imaging (fMRI) task.
Decoding fMRI alcohol cue reactivity and its association with drinking behaviour
http://orcid.org/0000-0002-9689-0583Haoye Tan1, Martin Fungisai Gerchen2,3,4, http://orcid.org/0000-0001-5962-019XPatrick Bach1, Alycia M Lee1, Oliver Hummel5, Wolfgang Sommer1,6,7, Peter Kirsch2,3,4, Falk Kiefer1,8,9, http://orcid.org/0000-0002-6210-672XSabine Vollstädt-Klein1,8 1Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty of Mannheim, Heidelberg University, Mannheim, Germany 2Department of Clinical Psychology, Central...
Deep brain stimulation of the nucleus accumbens in treatment-resistant alcohol use disorder: a double-blind randomized controlled multi-center trial - Translational Psychiatry
Study design and procedures The study was preregistered (German clinical trials database: DRKS00003206, EUDAMED ID: CIV-11-05-000663) and conducted in three German centers (Cologne, Magdeburg, and Mannheim/Heidelberg) as a double-blind randomized controlled trial (RCT).
Zum 50. von Silvia Seidel (†42) - Patrick Bach schreibt an „Anna“
Zum 50. von Silvia Seidel (†42) | Patrick Bach schreibt an „Anna“ Silvia Seidel und Patrick Bach begeisterten 1987 in der ZDF-Weihnachtsserie „Anna“ Millionen FansFoto: picture-alliance / Artikel von: Patrick Bach veröffentlicht am 23.09.2019 - 10:30 Uhr Silvia und ich haben uns zum ersten Mal 1987 am Set unserer gemeinsamen ZDF-Serie „Anna“ gesehen. Ich war zu dem Zeitpunkt schon kein Anfänger mehr, aber die Rolle war für mich dennoch eine gewisse Herausforderung.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Patrick
Contact Patrick, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack